What Researchers Did
Researchers reviewed records from 83 patients with severe traumatic brain injury to compare standard treatment against standard treatment plus HBOT.
What They Found
The HBOT group had an 80.95% overall treatment effectiveness rate compared to 60.98% in the control group. Brain injury biomarkers (S100β, NSE, GFAP) were significantly lower in HBOT patients, while brain growth factors (NGF and BDNF) were significantly higher. Neurological function scores also improved more in the HBOT group, with no added risk of side effects.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective study at a single institution in China, and the relatively small sample size of 83 patients limits how broadly the findings can be applied.